Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controversies over p25 in Alzheimer's disease.

× No keyword cloud information.

11 in total

Review 1. Targeting tau protein in Alzheimer's disease.

Authors: Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal: Drugs Aging Date: 2010-05 Impact factor: 3.923

Review 2. Tau as a therapeutic target for Alzheimer's disease.

Authors: A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal: Curr Alzheimer Res Date: 2011-09 Impact factor: 3.498

3. p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.

Authors: Rafael Andres Posada-Duque; Alejandro López-Tobón; Diego Piedrahita; Christian González-Billault; Gloria Patricia Cardona-Gomez
Journal: J Neurochem Date: 2015-05-04 Impact factor: 5.372

Review 4. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors: Chi-Tso Chiu; De-Maw Chuang
Journal: Pharmacol Ther Date: 2010-08-10 Impact factor: 12.310

5. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.

Authors: Katherine R Sadleir; Robert Vassar
Journal: J Biol Chem Date: 2012-01-05 Impact factor: 5.157

6. No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.

Authors: Dylan W Peterson; D Michael Ando; Daryl A Taketa; Hongjun Zhou; Fredrick W Dahlquist; John Lew
Journal: Proc Natl Acad Sci U S A Date: 2010-02-01 Impact factor: 11.205

Review 7. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors: C-X Gong; K Iqbal
Journal: Curr Med Chem Date: 2008 Impact factor: 4.530

Controversies over p25 in Alzheimer's disease.